Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis

NCT04717310 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

645

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: SHR0302 Ointment
DRUG: SHR0302 Ointment
DRUG: SHR0302 Ointment
DRUG: Vehicle

Sponsor

Reistone Biopharma Company Limited